Announced
Completed
Financials
Tags
news organization
Single Bidder
Publishing
Acquisition
Friendly
United States
Private
Cross Border
Majority
Completed
Synopsis
The Financial Times, a business news organisation, completed the acquisition of Endpoints News, a source of news and analysis for the thriving biopharmaceutical industry. Financial terms were not disclosed. “We’re thrilled to invest in Endpoints, a fast-growing business with a robust reputation for delivering quality news to audiences across the biopharma ecosystem. There is strong alignment between Endpoints and the FT in terms of mission, business model and focus on reader revenues. This acquisition also supports our ambitions to reach new audiences in innovative sectors and grow our footprint in the US,” John Ridding, FT CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.